These studies highlight a crucial role of neuronal regulation on the aggression of gliomas and suggest that neuron‐derived neurotrophins are potential therapeutic targets for the treatment of gliomas (Johung and Monje, 2017). Here, BDNF is linked to central nervous system cancer.